J99: Respiratory disorders in diseases classified elsewhere

J99 is a billable/specific diagnosis code from the 2026 ICD-10-CM used to classify the following condition: Respiratory disorders in diseases classified elsewhere.

Code first

Underlying disease, such as:

Amyloidosis (E85.-)
Ankylosing spondylitis (M45.-)
Congenital syphilis (A50.-)
Cryoglobulinemia (D89.1)
Early congenital syphilis (A50.0-)
Plasminogen deficiency (E88.02)
Schistosomiasis (B65.0-B65.9)

Type 1 excludes

Respiratory disorders in:

Amebiasis (A06.5)
Blastomycosis (B40.0-B40.2)
Candidiasis (B37.1)
Coccidioidomycosis (B38.0-B38.2)
Cystic fibrosis with pulmonary manifestations (E84.0)
Dermatomyositis (M33.01, M33.11)
Histoplasmosis (B39.0-B39.2)
Late syphilis (A52.72, A52.73)
Polymyositis (M33.21)
Sjögren syndrome (M35.02)
Systemic lupus erythematosus (M32.13)
Systemic sclerosis (M34.81)
Wegener's granulomatosis (M31.30-M31.31)

loading content...

Versions

2026
Code changed
- Type 1 excludes
  ~~respiratory disorders in:~~
  ~~amebiasis (A06.5)~~
  ~~blastomycosis (B40.0-B40.2)~~
  ~~candidiasis (B37.1)~~
  ~~coccidioidomycosis (B38.0-B38.2)~~
  ~~cystic fibrosis with pulmonary manifestations (E84.0)~~
  ~~dermatomyositis (M33.01, M33.11)~~
  ~~histoplasmosis (B39.0-B39.2)~~
  ~~late syphilis (A52.72, A52.73)~~
  ~~polymyositis (M33.21)~~
  ~~Sju00f6gren syndrome (M35.02)~~
  ~~systemic lupus erythematosus (M32.13)~~
  ~~systemic sclerosis (M34.81)~~
  ~~Wegener's granulomatosis (M31.30-M31.31)~~
  respiratory disorders in:
  amebiasis (A06.5)
  blastomycosis (B40.0-B40.2)
  candidiasis (B37.1)
  coccidioidomycosis (B38.0-B38.2)
  cystic fibrosis with pulmonary manifestations (E84.0)
  dermatomyositis (M33.01, M33.11)
  histoplasmosis (B39.0-B39.2)
  late syphilis (A52.72, A52.73)
  polymyositis (M33.21)
  Sjögren syndrome (M35.02)
  systemic lupus erythematosus (M32.13)
  systemic sclerosis (M34.81)
  Wegener's granulomatosis (M31.30-M31.31)
2025
Code changed
- Type 1 excludes
  ~~respiratory disorders in:~~
  ~~amebiasis (A06.5)~~
  ~~blastomycosis (B40.0-B40.2)~~
  ~~candidiasis (B37.1)~~
  ~~coccidioidomycosis (B38.0-B38.2)~~
  ~~cystic fibrosis with pulmonary manifestations (E84.0)~~
  ~~dermatomyositis (M33.01, M33.11)~~
  ~~histoplasmosis (B39.0-B39.2)~~
  ~~late syphilis (A52.72, A52.73)~~
  ~~polymyositis (M33.21)~~
  ~~Sjögren syndrome (M35.02)~~
  ~~systemic lupus erythematosus (M32.13)~~
  ~~systemic sclerosis (M34.81)~~
  ~~Wegener's granulomatosis (M31.30-M31.31)~~
  respiratory disorders in:
  amebiasis (A06.5)
  blastomycosis (B40.0-B40.2)
  candidiasis (B37.1)
  coccidioidomycosis (B38.0-B38.2)
  cystic fibrosis with pulmonary manifestations (E84.0)
  dermatomyositis (M33.01, M33.11)
  histoplasmosis (B39.0-B39.2)
  late syphilis (A52.72, A52.73)
  polymyositis (M33.21)
  Sju00f6gren syndrome (M35.02)
  systemic lupus erythematosus (M32.13)
  systemic sclerosis (M34.81)
  Wegener's granulomatosis (M31.30-M31.31)
2024
Code changed
- Code first
  ~~underlying disease, such as:~~
  ~~amyloidosis (E85.-)~~
  ~~ankylosing spondylitis (M45)~~
  ~~congenital syphilis (A50.5)~~
  ~~cryoglobulinemia (D89.1)~~
  ~~early congenital syphilis (A50.0)~~
  ~~plasminogen deficiency (E88.02)~~
  ~~schistosomiasis (B65.0-B65.9)~~
  underlying disease, such as:
  amyloidosis (E85.-)
  ankylosing spondylitis (M45.-)
  congenital syphilis (A50.-)
  cryoglobulinemia (D89.1)
  early congenital syphilis (A50.0-)
  plasminogen deficiency (E88.02)
  schistosomiasis (B65.0-B65.9)
2023
No changes
2022
Code changed
- Type 1 excludes
  ~~respiratory disorders in:~~
  ~~amebiasis (A06.5)~~
  ~~blastomycosis (B40.0-B40.2)~~
  ~~candidiasis (B37.1)~~
  ~~coccidioidomycosis (B38.0-B38.2)~~
  ~~cystic fibrosis with pulmonary manifestations (E84.0)~~
  ~~dermatomyositis (M33.01, M33.11)~~
  ~~histoplasmosis (B39.0-B39.2)~~
  ~~late syphilis (A52.72, A52.73)~~
  ~~polymyositis (M33.21)~~
  ~~sicca syndrome (M35.02)~~
  ~~systemic lupus erythematosus (M32.13)~~
  ~~systemic sclerosis (M34.81)~~
  ~~Wegener's granulomatosis (M31.30-M31.31)~~
  respiratory disorders in:
  amebiasis (A06.5)
  blastomycosis (B40.0-B40.2)
  candidiasis (B37.1)
  coccidioidomycosis (B38.0-B38.2)
  cystic fibrosis with pulmonary manifestations (E84.0)
  dermatomyositis (M33.01, M33.11)
  histoplasmosis (B39.0-B39.2)
  late syphilis (A52.72, A52.73)
  polymyositis (M33.21)
  Sjögren syndrome (M35.02)
  systemic lupus erythematosus (M32.13)
  systemic sclerosis (M34.81)
  Wegener's granulomatosis (M31.30-M31.31)
2021
No changes
2020
No changes
2019
Code changed
- Code first
  ~~underlying disease, such as:~~
  ~~amyloidosis (E85.-)~~
  ~~ankylosing spondylitis (M45)~~
  ~~congenital syphilis (A50.5)~~
  ~~cryoglobulinemia (D89.1)~~
  ~~early congenital syphilis (A50.0)~~
  ~~schistosomiasis (B65.0-B65.9)~~
  underlying disease, such as:
  amyloidosis (E85.-)
  ankylosing spondylitis (M45)
  congenital syphilis (A50.5)
  cryoglobulinemia (D89.1)
  early congenital syphilis (A50.0)
  plasminogen deficiency (E88.02)
  schistosomiasis (B65.0-B65.9)
2018
No changes
2017
No changes
2016
New code

loading versions...

Versions

2026

Code changed

Type 1 excludes
- - ~~respiratory disorders in:~~
  - ~~amebiasis (A06.5)~~
  - ~~blastomycosis (B40.0-B40.2)~~
  - ~~candidiasis (B37.1)~~
  - ~~coccidioidomycosis (B38.0-B38.2)~~
  - ~~cystic fibrosis with pulmonary manifestations (E84.0)~~
  - ~~dermatomyositis (M33.01, M33.11)~~
  - ~~histoplasmosis (B39.0-B39.2)~~
  - ~~late syphilis (A52.72, A52.73)~~
  - ~~polymyositis (M33.21)~~
  - ~~Sju00f6gren syndrome (M35.02)~~
  - ~~systemic lupus erythematosus (M32.13)~~
  - ~~systemic sclerosis (M34.81)~~
  - ~~Wegener's granulomatosis (M31.30-M31.31)~~
- - respiratory disorders in:
  - amebiasis (A06.5)
  - blastomycosis (B40.0-B40.2)
  - candidiasis (B37.1)
  - coccidioidomycosis (B38.0-B38.2)
  - cystic fibrosis with pulmonary manifestations (E84.0)
  - dermatomyositis (M33.01, M33.11)
  - histoplasmosis (B39.0-B39.2)
  - late syphilis (A52.72, A52.73)
  - polymyositis (M33.21)
  - Sjögren syndrome (M35.02)
  - systemic lupus erythematosus (M32.13)
  - systemic sclerosis (M34.81)
  - Wegener's granulomatosis (M31.30-M31.31)

2025

Code changed

Type 1 excludes
- - ~~respiratory disorders in:~~
  - ~~amebiasis (A06.5)~~
  - ~~blastomycosis (B40.0-B40.2)~~
  - ~~candidiasis (B37.1)~~
  - ~~coccidioidomycosis (B38.0-B38.2)~~
  - ~~cystic fibrosis with pulmonary manifestations (E84.0)~~
  - ~~dermatomyositis (M33.01, M33.11)~~
  - ~~histoplasmosis (B39.0-B39.2)~~
  - ~~late syphilis (A52.72, A52.73)~~
  - ~~polymyositis (M33.21)~~
  - ~~Sjögren syndrome (M35.02)~~
  - ~~systemic lupus erythematosus (M32.13)~~
  - ~~systemic sclerosis (M34.81)~~
  - ~~Wegener's granulomatosis (M31.30-M31.31)~~
- - respiratory disorders in:
  - amebiasis (A06.5)
  - blastomycosis (B40.0-B40.2)
  - candidiasis (B37.1)
  - coccidioidomycosis (B38.0-B38.2)
  - cystic fibrosis with pulmonary manifestations (E84.0)
  - dermatomyositis (M33.01, M33.11)
  - histoplasmosis (B39.0-B39.2)
  - late syphilis (A52.72, A52.73)
  - polymyositis (M33.21)
  - Sju00f6gren syndrome (M35.02)
  - systemic lupus erythematosus (M32.13)
  - systemic sclerosis (M34.81)
  - Wegener's granulomatosis (M31.30-M31.31)

2024

Code changed

Code first
- - ~~underlying disease, such as:~~
  - ~~amyloidosis (E85.-)~~
  - ~~ankylosing spondylitis (M45)~~
  - ~~congenital syphilis (A50.5)~~
  - ~~cryoglobulinemia (D89.1)~~
  - ~~early congenital syphilis (A50.0)~~
  - ~~plasminogen deficiency (E88.02)~~
  - ~~schistosomiasis (B65.0-B65.9)~~
- - underlying disease, such as:
  - amyloidosis (E85.-)
  - ankylosing spondylitis (M45.-)
  - congenital syphilis (A50.-)
  - cryoglobulinemia (D89.1)
  - early congenital syphilis (A50.0-)
  - plasminogen deficiency (E88.02)
  - schistosomiasis (B65.0-B65.9)

2023

No changes

2022

Code changed

Type 1 excludes
- - ~~respiratory disorders in:~~
  - ~~amebiasis (A06.5)~~
  - ~~blastomycosis (B40.0-B40.2)~~
  - ~~candidiasis (B37.1)~~
  - ~~coccidioidomycosis (B38.0-B38.2)~~
  - ~~cystic fibrosis with pulmonary manifestations (E84.0)~~
  - ~~dermatomyositis (M33.01, M33.11)~~
  - ~~histoplasmosis (B39.0-B39.2)~~
  - ~~late syphilis (A52.72, A52.73)~~
  - ~~polymyositis (M33.21)~~
  - ~~sicca syndrome (M35.02)~~
  - ~~systemic lupus erythematosus (M32.13)~~
  - ~~systemic sclerosis (M34.81)~~
  - ~~Wegener's granulomatosis (M31.30-M31.31)~~
- - respiratory disorders in:
  - amebiasis (A06.5)
  - blastomycosis (B40.0-B40.2)
  - candidiasis (B37.1)
  - coccidioidomycosis (B38.0-B38.2)
  - cystic fibrosis with pulmonary manifestations (E84.0)
  - dermatomyositis (M33.01, M33.11)
  - histoplasmosis (B39.0-B39.2)
  - late syphilis (A52.72, A52.73)
  - polymyositis (M33.21)
  - Sjögren syndrome (M35.02)
  - systemic lupus erythematosus (M32.13)
  - systemic sclerosis (M34.81)
  - Wegener's granulomatosis (M31.30-M31.31)

2021

No changes

2020

No changes

2019

Code changed

Code first
- - ~~underlying disease, such as:~~
  - ~~amyloidosis (E85.-)~~
  - ~~ankylosing spondylitis (M45)~~
  - ~~congenital syphilis (A50.5)~~
  - ~~cryoglobulinemia (D89.1)~~
  - ~~early congenital syphilis (A50.0)~~
  - ~~schistosomiasis (B65.0-B65.9)~~
- - underlying disease, such as:
  - amyloidosis (E85.-)
  - ankylosing spondylitis (M45)
  - congenital syphilis (A50.5)
  - cryoglobulinemia (D89.1)
  - early congenital syphilis (A50.0)
  - plasminogen deficiency (E88.02)
  - schistosomiasis (B65.0-B65.9)

2018

No changes

2017

No changes

2016

New code